[Form 4] ROCKWELL MEDICAL, INC. Insider Trading Activity

Rhea-AI Filing Summary

Rockwell Medical director reports new equity awards

A director of Rockwell Medical, Inc. (RMTI) reported receiving equity compensation on November 17, 2025. The filing shows an award of 25,000 shares of common stock, described as restricted stock units that vest on November 17, 2026, subject to continued service. After this grant, the director beneficially owns 25,000 common shares directly.

The director was also granted stock options for 25,000 shares of common stock at an exercise price of $0.87 per share, expiring on November 17, 2035. These options vest on November 17, 2026, also conditioned on continued service. The Form 4 notes that it is being filed late due to administrative delays in obtaining the director’s EDGAR codes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dawson Joseph H

(Last) (First) (Middle)

C/O ROCKWELL MEDICAL, INC.

30142 WIXOM ROAD

(Street)

WIXOM MI 48393

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		A(1)		25,000	A	$0	25,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.87	11/17/2025		A		25,000		(2)	11/17/2035	Common Stock	25,000	$0	25,000	D

Explanation of Responses:

1. Restricted stock units vest on November 17, 2026, subject to the Reporting Person's continued service to the Issuer.

2. Stock options vest on November 17, 2026, subject to the Reporting Person's continued service to the Issuer.

Remarks:

This Form 4 is being filed late due to administrative delays in obtaining the Reporting Person's EDGAR codes.

	/s/ Megan Timmins, Attorney-in-Fact for Joseph Dawson	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Rockwell Medical (RMTI) report on this Form 4?

The Form 4 reports that a director of Rockwell Medical, Inc. received a grant of 25,000 shares of common stock (described as restricted stock units) and stock options for 25,000 shares on November 17, 2025.

How many Rockwell Medical (RMTI) shares and options were granted to the director?

The director was granted 25,000 shares of common stock and stock options covering 25,000 shares of Rockwell Medical common stock.

What are the vesting terms of the Rockwell Medical (RMTI) restricted stock units and options?

The restricted stock units vest on November 17, 2026, subject to the director’s continued service to the company. The stock options also vest on November 17, 2026 under the same continued service condition.

What is the exercise price and expiration date of the Rockwell Medical (RMTI) stock options?

The stock options have an exercise price of $0.87 per share and an expiration date of November 17, 2035.

How many Rockwell Medical (RMTI) securities does the director beneficially own after this transaction?

After the reported transaction, the director beneficially owns 25,000 shares of Rockwell Medical common stock directly and 25,000 stock options linked to the company’s common stock.

Why was this Rockwell Medical (RMTI) Form 4 filed late?

The Form 4 states that it is being filed late due to administrative delays in obtaining the Reporting Person's EDGAR codes.